What this deck covers
This deck focuses on Indications And Dosing Regimens, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Indications And Dosing Regimens in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
What is the standard adult dosing regimen for acute asthma exacerbation oral corticosteroid "burst"?
Tap card or press Space to flip
Prednisone 40–60 mg PO daily for 5–7 days. Provides rapid anti-inflammatory effects to reduce airway inflammation and improve lung function in acute exacerbations.
How well did you know it?
Card 1 / 23
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Indications And Dosing Regimens, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Prednisone 40–60 mg PO daily for 5–7 days. Provides rapid anti-inflammatory effects to reduce airway inflammation and improve lung function in acute exacerbations.
Answer: Valacyclovir 500 mg PO BID for 3 days. Suppresses herpes simplex virus replication during outbreaks, reducing lesion duration and viral shedding in recurrent episodes.
Answer: Metformin IR 500 mg PO daily or BID with meals; titrate weekly as tolerated. Starts at low dose to minimize gastrointestinal side effects while improving glycemic control through reduced hepatic glucose production.
Answer: TMP-SMX DS 160/800 mg PO BID for 3 days. Provides effective coverage against susceptible uropathogens with a short course to minimize resistance development when local resistance is below 20%.
Answer: Levothyroxine about 1.6 kgmcg PO daily (full replacement in healthy adults). Weight-based dosing approximates full thyroid hormone replacement to normalize TSH levels without overtreatment in euthyroid goal.
Answer: Benzathine penicillin G 2.4 million units IM once. Delivers treponemacidal levels to eradicate Treponema pallidum in early stages, preventing progression to secondary syphilis.
Answer: Doxycycline 100 mg PO BID for 5–7 days. Offers broad coverage including atypicals and some gram-positives, serving as an alternative for patients intolerant to macrolides or beta-lactams.
Answer: Omeprazole 20 mg PO daily for 4–8 weeks. Suppresses gastric acid production to promote esophageal healing and symptom relief in erosive or non-erosive reflux disease.
Answer: Vancomycin 125 mg PO QID for 10 days. Targets C. difficile toxins directly in the gut with minimal systemic absorption, standard for initial mild episodes to reduce recurrence risk.
Answer: Ceftriaxone 500 mg IM once (add doxycycline if chlamydia not excluded). High-dose ceftriaxone ensures effective treatment of gonorrhea with added doxycycline to cover potential chlamydial co-infection.
Answer: Azithromycin 500 mg PO day 1, then 250 mg daily days 2–5. This macrolide regimen covers atypical pathogens like Mycoplasma and Chlamydia, suitable for healthy outpatients with low risk of resistance.
Answer: Oseltamivir 75 mg PO BID for 5 days. Inhibits influenza neuraminidase to reduce viral replication and symptom duration when started within 48 hours of onset.
Answer: Lisinopril 10 mg PO daily (lower if on diuretic or CKD per clinician judgment). Initiates ACE inhibition at a dose balancing efficacy and tolerability, adjustable based on blood pressure response and comorbidities.
Answer: Nitrofurantoin 100 mg PO BID for 5 days. Recommended as first-line due to high efficacy against E. coli with low resistance rates and favorable safety profile in nonpregnant women without complicating factors.
Answer: Metronidazole 500 mg PO BID for 7 days. Achieves high tissue concentrations to eradicate Trichomonas vaginalis, preferred for its efficacy and tolerability in symptomatic women.
Answer: Doxycycline 100 mg PO BID for 7 days. Provides effective intracellular activity against Chlamydia trachomatis, ensuring clearance in uncomplicated genital infections.
Answer: Fidaxomicin 200 mg PO BID for 10 days. Inhibits C. difficile RNA polymerase, providing high efficacy and lower recurrence rates compared to vancomycin for initial infections.
Answer: Benzathine penicillin G 2.4 million units IM weekly for 3 doses. Ensures prolonged treponemacidal activity to treat potential persistent organisms in latent stages without neurologic involvement.
Answer: Isoniazid + rifapentine once weekly for 12 weeks (directly observed or self-administered per protocol). Short-course combination targets latent Mycobacterium tuberculosis with high completion rates and efficacy equivalent to longer regimens.
Answer: PPI BID + amoxicillin 1 g BID + clarithromycin 500 mg BID for 14 days. Utilizes acid suppression with dual antibiotics targeting H. pylori in regions with low clarithromycin resistance for effective eradication.
Answer: Oseltamivir 75 mg PO daily for 7 days after last exposure. Prevents influenza replication in exposed individuals, reducing infection risk in close contacts during outbreaks.
Answer: Fosfomycin tromethamine 3 g PO once. Single-dose administration inhibits bacterial cell wall synthesis, offering convenience and high efficacy for uncomplicated cases caused by susceptible organisms.
Answer: Valacyclovir 1 g PO TID for 7 days. Inhibits varicella-zoster virus replication to shorten rash duration and reduce postherpetic neuralgia risk in immunocompetent adults.